Charles Schwab Investment Management Inc Astrazeneca PLC Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,784,235 shares of AZN stock, worth $120 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,784,235

Previous 1,775,405 0.5%

Holding current value

$120 Million

Previous $138 Million 0.41%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $676,996 - $773,684	8,830 Added 0.5%	1,784,235 $139 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $111 Million - $135 Million	1,666,500 Added 1530.23%	1,775,405 $138 Million
Q1 2024 May 08, 2024	SELL	$61.03 - $69.57 $2.34 Million - $2.67 Million	-38,346 Reduced 26.04%	108,905 $7.38 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $1.5 Million - $1.68 Million	24,233 Added 19.7%	147,251 $9.92 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $5.62 Million - $6.21 Million	86,610 Added 237.89%	123,018 $8.33 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $1.17 Million - $1.27 Million	16,736 Added 85.08%	36,408 $2.61 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $455,753 - $516,737	7,217 Added 57.94%	19,672 $1.37 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $675,185 - $877,330	12,455 New	12,455 $844,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $1.7 Million - $1.97 Million	-36,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $10.1 Million - $12.1 Million	-208,900 Reduced 85.27%	36,100 $1.81 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $3.93 Million - $4.52 Million	-74,000 Reduced 23.2%	245,000 $13.4 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $7.49 Million - $9.61 Million	-173,700 Reduced 35.25%	319,000 $16.9 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $6.19 Million - $8.41 Million	-163,800 Reduced 24.95%	492,700 $22 Million
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $7.79 Million - $9.26 Million	-183,500 Reduced 21.85%	656,500 $32.7 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $29.8 Million - $36.1 Million	840,000 New	840,000 $34 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Astrazeneca PLC Transaction History